Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9400 (-2.73%) ($6.9400 - $6.9400) on Thu. Jun. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 8 | Latest Price | $6.9400(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -8.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) BND(27%) VCIT(27%) LQD(25%) IBB(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.41% in a week (0% probabilities). XLRE(-24%) XLP(-22%) TBT(-20%) SPLV(-20%) DIA(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.71(-225.5%) | Resistance Level | $7.78 | 5 Day Moving Average | $7.04(-1.42%) | 10 Day Moving Average | $7.19(-3.48%) | 20 Day Moving Average | $7.78(-10.8%) | To recent high | -21.6% | To recent low | 0% | Market Cap | $1.224b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |